The report on the Key Biologics Sector outlook provides a comprehensive analysis of two primary areas: recombinant proteins and vaccine adjuvants. It outlines the current market, ecosystem, advancements in recombinant protein technologies, focusing on their applications, growth drivers & challenges.

Additionally, the report covers vaccine adjuvants, detailing their role in enhancing vaccine efficacy and the innovations driving their development. It further addresses market dynamics, regulatory frameworks, competitive landscapes, and future growth opportunities within these segments.